Tidal Investments LLC Invests $879,000 in Option Care Health, Inc. (NASDAQ:OPCH)

Tidal Investments LLC purchased a new stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 37,881 shares of the company's stock, valued at approximately $879,000.

Other large investors also recently bought and sold shares of the company. JPMorgan Chase & Co. lifted its holdings in Option Care Health by 29.6% in the fourth quarter. JPMorgan Chase & Co. now owns 1,511,403 shares of the company's stock valued at $35,065,000 after acquiring an additional 344,875 shares during the period. MetLife Investment Management LLC lifted its holdings in Option Care Health by 7.8% in the fourth quarter. MetLife Investment Management LLC now owns 197,219 shares of the company's stock valued at $4,575,000 after acquiring an additional 14,311 shares during the period. Charles Schwab Investment Management Inc. lifted its holdings in Option Care Health by 6.2% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company's stock valued at $58,235,000 after acquiring an additional 147,054 shares during the period. Global Alpha Capital Management Ltd. lifted its holdings in Option Care Health by 38.1% in the fourth quarter. Global Alpha Capital Management Ltd. now owns 68,810 shares of the company's stock valued at $1,596,000 after acquiring an additional 18,992 shares during the period. Finally, Y Intercept Hong Kong Ltd acquired a new position in Option Care Health in the fourth quarter valued at approximately $327,000. 98.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on OPCH shares. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and boosted their price target for the company from $38.00 to $40.00 in a report on Wednesday, April 30th. JMP Securities reissued a "market outperform" rating and issued a $36.00 price target on shares of Option Care Health in a report on Tuesday, April 22nd. Barrington Research reissued an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a report on Wednesday, April 30th. Finally, JPMorgan Chase & Co. boosted their price objective on Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research report on Thursday, March 6th. One analyst has rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, Option Care Health has a consensus rating of "Moderate Buy" and an average price target of $35.50.

Option Care Health Price Performance

Shares of Option Care Health stock traded down $0.38 on Wednesday, reaching $31.74. The company's stock had a trading volume of 881,761 shares, compared to its average volume of 1,858,425. The company has a market capitalization of $5.20 billion, a P/E ratio of 26.67, a PEG ratio of 2.30 and a beta of 0.76. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53. The stock has a 50-day moving average price of $32.89 and a 200-day moving average price of $29.47. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating analysts' consensus estimates of $0.36 by $0.04. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The business had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.26 billion. During the same period in the previous year, the business earned $0.26 earnings per share. The business's revenue was up 16.3% compared to the same quarter last year. Analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current year.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now directly owns 44,974 shares in the company, valued at $1,495,835.24. This represents a 40.80% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.64% of the stock is owned by company insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.